- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Dublin Today
By the People, for the People
ZEISS Unveils Digital and AI Innovations for Ophthalmic Workflows at ASCRS
New tools and technologies aim to enhance cataract surgery efficiency and patient outcomes.
Apr. 3, 2026 at 2:48am
Got story updates? Submit your updates here. ›
ZEISS's new digital and surgical innovations promise to streamline ophthalmic workflows and enhance patient care.Dublin TodayZEISS Medical Technology is showcasing a range of new digital, AI, and surgical innovations at the upcoming ASCRS conference, including expanded cataract workflow tools, enhanced IOL calculation capabilities, a human-verified AI-powered patient engagement platform, and cloud-based workflow solutions to improve care coordination and clinical insights.
Why it matters
These ZEISS innovations are designed to help ophthalmology practices streamline workflows, improve patient experiences and outcomes, and leverage data and technology to deliver more efficient and effective care across cataract, refractive, and retinal procedures.
The details
Key ZEISS offerings debuting at ASCRS include new irrigation/aspiration handpieces, tips and sleeves for the DORC EVA NEXUS surgical system to support a broader range of incision sizes and improve sustainability; expanded calculation capabilities in the ZEISS IOLMaster 700 and ZEISS VERACITY Surgery Planner to aid toric IOL selection and post-LVC cataract management; the commercial launch of the ZEISS VisioGen AI-powered patient engagement platform; and the new ZEISS Collaborative Care and ZEISS CLINIC 360 cloud-based workflow solutions.
- ZEISS will showcase its latest offerings at the ASCRS conference from April 10-12, 2026 in Washington, D.C.
- The ZEISS VisioGen patient engagement platform is now commercially available in the U.S.
- The ZEISS CLINIC 360 software solution is pending 510(k) clearance and not yet available for sale or use in the U.S.
The players
ZEISS Medical Technology
One of the world's leading medical technology companies, specializing in ophthalmic innovations.
Magnus Reibenspiess
Chief Commercial Officer and Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology.
Dr. Dan Haddad
Medical Director at Laser Eye Institute in Troy, Michigan.
What they’re saying
“Unlike fully automated chatbots, VisioGen requires human review before any patient-facing response is delivered. This provides the speed of AI with the oversight needed for clinical safety, appropriate tone, and regulatory compliance. This level of oversight is essential to protecting our brand and maintaining patient trust.”
— Dr. Dan Haddad, Medical Director, Laser Eye Institute
What’s next
ZEISS will showcase its latest offerings and new innovations at the American Society of Cataract and Refractive Surgery (ASCRS) conference from April 10-12, 2026, in Washington, D.C., at booth #607.
The takeaway
ZEISS's new digital, AI, and surgical innovations aim to help ophthalmology practices enhance workflow efficiency, improve patient experiences and outcomes, and leverage data-driven insights across cataract, refractive, and retinal procedures.
